Assembly Biosciences
ASMB
49 hedge funds and large institutions have $301M invested in Assembly Biosciences in 2017 Q1 according to their latest regulatory filings, with 19 funds opening new positions, 15 increasing their positions, 7 reducing their positions, and 2 closing their positions.
850% more first-time investments, than exits
New positions opened: 19 | Existing positions closed: 2
189% more call options, than puts
Call options by funds: $5.24M | Put options by funds: $1.81M
115% more capital invested
Capital invested by funds: $140M → $301M (+$161M)
114% more repeat investments, than reductions
Existing positions increased: 15 | Existing positions reduced: 7
36% more funds holding
Funds holding: 36 → 49 (+13)
0.11% more ownership
Funds ownership: 5.64% → 5.75% (+0.11%)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACA
Avoro Capital Advisors
New York
|
+$8.71M |
| 2 |
BlackRock
New York
|
+$6.59M |
| 3 |
ACP
Acuta Capital Partners
Redwood City,
California
|
+$2.52M |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$2.08M |
| 5 |
Goldman Sachs
New York
|
+$1.26M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PI
Putnam Investments
Boston,
Massachusetts
|
-$4.43M |
| 2 |
O
OrbiMed
New York
|
-$2.86M |
| 3 |
Millennium Management
New York
|
-$2.17M |
| 4 |
QF
QVT Financial
New York
|
-$1.98M |
| 5 |
Jennison Associates
New York
|
-$1.27M |
ASMB Hedge Fund Activity: Q1 2017 in Review
49 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in Assembly Biosciences (ASMB) for Q1 2017, worth a combined $301M — up 115% from $140M a quarter earlier.
Buyers outnumbered sellers: 19 funds opened new ASMB positions and 2 closed out — a net gain of 17 holders — while 15 added to existing stakes and 7 trimmed.
The largest buyer was Avoro Capital Advisors, adding an estimated $8.71M. The largest seller was Putnam Investments, exiting entirely with an estimated $4.43M sold.
- 49 institutional investors held Assembly Biosciences (ASMB) as of Q1 2017, up from 36 in Q4 2016.
- Funds reported $301M of Assembly Biosciences stock for Q1 2017, up 115% quarter-over-quarter.
- 19 funds opened new Assembly Biosciences positions in Q1 2017 and 2 closed out, a net change of +17 holders.
- The largest Assembly Biosciences buyer in Q1 2017 was Avoro Capital Advisors, an estimated $8.71M added.
- The largest Assembly Biosciences seller in Q1 2017 was Putnam Investments, an estimated $4.43M sold.
Based on aggregated 13F filings for Q1 2017.